MYD88 and hepatocellular carcinoma: In order to further analyze the correlation between lnc-MyD88 expression and various clinicopathological data, we divided HCC patients into high lnc-MyD88 expressed group (n = 49) and low lnc-MyD88 expressed group (n = 49) based on the median value.